Illumina/ILMN

$136.97

2.98%
-
1D1W1MYTD1YMAX

About Illumina

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

Ticker

ILMN

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Jacob Thaysen

Employees

10,590

Headquarters

San diego, United States

Illumina Metrics

BasicAdvanced
$21.13B
Market cap
-
P/E ratio
-$7.34
EPS
1.18
Beta
-
Dividend rate

What the Analysts think about Illumina

Analyst Ratings

Majority rating from 24 analysts.
Hold

Price Targets

Average projection from 21 analysts.
11.56% upside
High $258.00
Low $85.00
$136.97
Current price
$152.81
Average price target

Illumina Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.59% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.12B
0.27%
Net income
$-175M
-76.79%
Profit margin
-15.59%
-76.86%

Illumina Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 685.94%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.08
$0.32
$0.33
$0.14
-
Expected
$0.03
$0.02
$0.12
$0.02
$0.04
Surprise
215.79%
1,636.39%
167.61%
685.94%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Illumina stock

Buy or sell Illumina stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing